76784-92-4

Upstream product

• 76784-89-9 methyl 4-amino-2-methoxycarbonylmethylbenzoate 
• 408335-76-2 4-amino-2-(carboxymethyl)benzoic acid 
• 65399-05-5 5-amino-3H-isobenzofuran-1-one 
• 76784-90-2 methyl 4-cyano-2-methoxycarbonylmethylbenzoate 

Downstream Products

• 76784-94-6 dimethyl 2-methoxycarbonylmethyl-1,4-cyclohexanedicarboxylate 
• 76784-93-5 dimethyl 2-methoxycarbonylmethylterephthalate 

Relevant academic research and scientific papers

Naaladase inhibitors for treating retinal disorders and glaucoma

The present invention relates to pharmaceutical compositions and methods for treating a retinal disorder or glaucoma using NAALADase inhibitors.

Naaladase inhibitors for treating amyotrophic lateral sclerosis

The present invention relates to pharmaceutical compositions and methods for treating amyotrophic lateral sclerosis using NAALADase inhibitors.

Benzenedicarboxylic acid derivatives

New benzenedicarboxylic acid derivative compounds; pharmaceutical compositions, diagnostic methods, and diagnstic kits that include those compounds; and methods of using those compounds for inhibiting NAALADase enzyme activity, detecting diseases where NAALADase levels are altered, effecting neuronal activity, effecting TGF-β activity, inhibiting angiogenesis, and treating glutamate abnormalities, neutopathy, pain, compulsive disorders, prostate diseases, cancers, and glaucoma.